Literature DB >> 1131815

Effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells.

M Ogawa, G R Gale, S S Keirn.   

Abstract

The effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells were studied in culture. When murine cells from normal and actively regenerating marrows were exposed to cis-diamminedichloroplatinum in culture, washed free of the agent, and assayed for the surviving hemopoietic precursor cells, similar sensitivity curves were obtained. This result indicates the absence of cell-cycle dependency of cis-diaminedichloroplatinum. When marrow cells were exposed to cis-diamminedichloroplatinum in culture at various temperatures, only minimal reduction of cytotoxicity was noted at 4 degrees. This observation, unlike that from the experiment with nitrogen mustard, suggests that the transport of this agent is by passive diffusion. Finally, when the sensitivity of human hemopoietic precursor cells to this agent was assessed using similar conditions and compared to that of murine hemopoietic precursor cells, a significant species difference was observed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1131815

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

2.  Some effects of chemotherapeutic drugs. III. Short- and long-term effects of cis-platinum on various hematopoietic compartments and on the kidney of the mouse.

Authors:  D Dumenil; D Droz; J P Droz; E Frindel
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([189, 191Pt]cisplatin) Emitting Auger Electrons.

Authors:  Honoka Obata; Atsushi B Tsuji; Hitomi Sudo; Aya Sugyo; Katsuyuki Minegishi; Kotaro Nagatsu; Mikako Ogawa; Ming-Rong Zhang
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

4.  Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow.

Authors:  L Bettan-Renaud; F de Vathaire; J Bénard; N Morardet; N Pauzie; S Bayet; O Hartmann; C Parmentier
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

Review 5.  Cellular accumulation of the anticancer agent cisplatin: a review.

Authors:  D P Gately; S B Howell
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

6.  Effects of cisplatin on different haemopoietic progenitor cells in mice.

Authors:  M R Nowrousian; C G Schmidt
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.